Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
mRNA-binding protein involved in translation elongation. Additionally we are shipping EIF5A2 Proteins (18) and many more products for this protein.
Showing 10 out of 68 products:
Human Polyclonal EIF5A2 Primary Antibody for IHC (p), WB - ABIN657973
Xie, Ma, Pan, Wu, Liu, Wu, Kung, Guan: Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. in Human pathology 2007
Human Polyclonal EIF5A2 Primary Antibody for ICC, IF - ABIN4307679
Murata, Minami, Iwakawa, Yokota, Usui, Tsuta, Shiraishi, Sakashita, Satomi, Iijima, Noguchi: ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma. in Cancer science 2014
Human Monoclonal EIF5A2 Primary Antibody for ELISA, WB - ABIN566034
Fujimura, Wright, Strnadel, Kaushal, Metildi, Lowy, Bouvet, Kelber, Klemke: A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. in Cancer research 2014
MiR (show MLXIP Antibodies)-30b suppresses tumor migration and invasion by targeting EIF5A2 expression in gastric cancer cells.
eIF-5A2 plays an important role in doxorubicin chemoresistance in breast cancer cells.
Data indicate that regulation of sonic hedgehog (SHh (show SHH Antibodies))-GLI family zinc finger 1 (Gli1 (show GLI1 Antibodies)) signals to migration of pancreatic cancer AsPC-1 Cells through mediating eukaryotic translation initiation factor 5A (EIF5A2) gene expression.
Data suggest that eukaryotic translation initiation factor 5A2 (EIF5A2) inhibitors might be considered as combination therapy to enhance chemosensitivity in patients with esophageal squamous cell carcinoma (ESCC).
Our findings indicate that EIF5A2 upregulation plays an important oncogenic role in gastric cancer. EIF5A2 may represent a new predictor for poor survival and is a potential therapeutic target for gastric cancer.
Increased expression of eIF5A2 increases metastasis and angiogenesis in esophageal squamous cell carcinoma via the HIF1alpha (show HIF1A Antibodies)-mediated signaling pathway.
focus on updating current knowledge of the EIF5A2 gene in human cancers
EIF5A2 elevated TGF-beta1 (show TGFB1 Antibodies) expression through STAT3 (show STAT3 Antibodies) to induce epithelial-mesenchymal transition and promotes aggressiveness in bladder cancer.
It significantly inhibited activity of eIF5A2.
None of the latter died within 5 years in EIF5A2-negative staining group.
activation of eIF-5A2 repressed p19 level and therefore destabilized p53 in transgenic mouse embryo fibroblast (MEF) cells. This subsequently allowed for the accumulation of chromosomal instability.
Eukaryotic initiation factor 5A (eIF5A) (eIF-4D (show EIF5A Antibodies), eIF-5A (show EIF5A Antibodies)) stimulates ribosomal peptidyltransferase activity, transport of HIV-1-mRNAs and binds exportins 1 and 4. Contains hypusine at lys (show LYZ Antibodies) 50. Mouse EIF5A1 (show EIF5A Antibodies) and EIF5A2 encode two isoforms: eIF5AI (show EIF5A Antibodies) and eIF5AII.
mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. Functions as a regulator of apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation (By similarity).
eukaryotic translation initiation factor 5A-2
, eukaryotic translation initiation factor 5A2
, eukaryotic translation initiation factor 5A
, eukaryotic translation initiation factor 5A3
, eukaryotic initiation factor 5A
, initiation factor 5A